{"database": "lobbying", "table": "lobbying_activities", "rows": [[1733020, "1bc29771-b831-417f-a5de-a6b763413d93", "3A", "AMERICAN VETERINARY MEDICAL ASSOCIATION", 3630, "AMERICAN VETERINARY MEDICAL ASSOCIATION", 2015, "third_quarter", "PHA", "Guidance for Industry: Compounding Animal Drugs from Bulk Substances\nDiscussions with Congressional staff, FDA and USDA regarding the use of antimicrobials in food-producing animals, particularly with respect to H.R.1552 (Preservation of Antibiotics for Medical Treatment Act), S. 621 (Preventing Antibiotic Resistance Act), and FDA's strategy (GRI #209 and VFD Rule)\nDiscussions with Congressional staff, FDA and Government Accountability Office to express the need for compounding of medications for use in animals and FDA's draft GFI #230\nInquiries to, and discussions with, Congressional staff on veterinary pet prescriptions, particularly regarding H.R. 317/S. 1200, the Fairness to Pet Owners Act.", "Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE", null, 220000, 0, 0, "2015-10-16T09:05:14.283000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1733020"], "units": {}, "query_ms": 0.357357959728688, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}